118 related articles for article (PubMed ID: 32913547)
1. MiRNA-27a-3p induces temozolomide resistance in glioma by inhibiting NF1 level.
Li S; Li W; Chen G; Huang J; Li W
Am J Transl Res; 2020; 12(8):4749-4756. PubMed ID: 32913547
[TBL] [Abstract][Full Text] [Related]
2. MicoRNA-214-3p: a key player in CPLX2-mediated inhibition on temozolomide resistance in glioma.
Peng Q; Wang L; Wang S; Wang C; Xue Z
Neurol Res; 2022 Oct; 44(10):879-887. PubMed ID: 36117461
[TBL] [Abstract][Full Text] [Related]
3. miR-126-3p sensitizes glioblastoma cells to temozolomide by inactivating Wnt/β-catenin signaling via targeting SOX2.
Luo W; Yan D; Song Z; Zhu X; Liu X; Li X; Zhao S
Life Sci; 2019 Jun; 226():98-106. PubMed ID: 30980849
[TBL] [Abstract][Full Text] [Related]
4. MiR-27a-3p/miR-27b-3p Promotes Neurofibromatosis Type 1 via Targeting of NF1.
Lu H; Liu P; Pang Q
J Mol Neurosci; 2021 Nov; 71(11):2353-2363. PubMed ID: 33570696
[TBL] [Abstract][Full Text] [Related]
5. MiRNA-27a-3p promotes osteogenic differentiation of human mesenchymal stem cells through targeting ATF3.
Fu YC; Zhao SR; Zhu BH; Guo SS; Wang XX
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(3 Suppl):73-80. PubMed ID: 31389577
[TBL] [Abstract][Full Text] [Related]
6. Forkhead box protein O3a promotes glioma cell resistance to temozolomide by regulating matrix metallopeptidase and β-catenin.
Sun D; Yang S; Zhang X; Li S; Wang L; Chen J; Qiu C; Xu K
Oncol Lett; 2021 Apr; 21(4):328. PubMed ID: 33692860
[TBL] [Abstract][Full Text] [Related]
7. Bortezomib inhibits growth and sensitizes glioma to temozolomide (TMZ) via down-regulating the FOXM1-Survivin axis.
Tang JH; Yang L; Chen JX; Li QR; Zhu LR; Xu QF; Huang GH; Zhang ZX; Xiang Y; Du L; Zhou Z; Lv SQ
Cancer Commun (Lond); 2019 Dec; 39(1):81. PubMed ID: 31796105
[TBL] [Abstract][Full Text] [Related]
8. Biochemical changes associated with a multidrug-resistant phenotype of a human glioma cell line with temozolomide-acquired resistance.
Ma J; Murphy M; O'Dwyer PJ; Berman E; Reed K; Gallo JM
Biochem Pharmacol; 2002 Apr; 63(7):1219-28. PubMed ID: 11960598
[TBL] [Abstract][Full Text] [Related]
9. LRRC8A potentiates temozolomide sensitivity in glioma cells via activating mitochondria-dependent apoptotic pathway.
Yang C; He L; Chen G; Ning Z; Xia Z
Hum Cell; 2019 Jan; 32(1):41-50. PubMed ID: 30426452
[TBL] [Abstract][Full Text] [Related]
10. Akt and β-catenin contribute to TMZ resistance and EMT of MGMT negative malignant glioma cell line.
Yi GZ; Liu YW; Xiang W; Wang H; Chen ZY; Xie SD; Qi ST
J Neurol Sci; 2016 Aug; 367():101-6. PubMed ID: 27423571
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA‑27a‑3p regulates the proliferation and chemotaxis of pulmonary macrophages in non‑small cell lung carcinoma tissues through CXCL2.
Zhai C; Liu B; Kan F; Zhai S; Zhang R
Oncol Lett; 2023 Nov; 26(5):492. PubMed ID: 37854860
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-141-3p promotes glioma cell growth and temozolomide resistance by directly targeting p53.
Zhou X; Wu W; Zeng A; Nie E; Jin X; Yu T; Zhi T; Jiang K; Wang Y; Zhang J; You Y
Oncotarget; 2017 Sep; 8(41):71080-71094. PubMed ID: 29050344
[TBL] [Abstract][Full Text] [Related]
13. Long Non-Coding RNA MALAT1 Decreases the Sensitivity of Resistant Glioblastoma Cell Lines to Temozolomide.
Li H; Yuan X; Yan D; Li D; Guan F; Dong Y; Wang H; Liu X; Yang B
Cell Physiol Biochem; 2017; 42(3):1192-1201. PubMed ID: 28668966
[TBL] [Abstract][Full Text] [Related]
14. Improved effects of honokiol on temozolomide-induced autophagy and apoptosis of drug-sensitive and -tolerant glioma cells.
Chio CC; Chen KY; Chang CK; Chuang JY; Liu CC; Liu SH; Chen RM
BMC Cancer; 2018 Apr; 18(1):379. PubMed ID: 29614990
[TBL] [Abstract][Full Text] [Related]
15. Knockdown of long noncoding RNA H19 sensitizes human glioma cells to temozolomide therapy.
Jiang P; Wang P; Sun X; Yuan Z; Zhan R; Ma X; Li W
Onco Targets Ther; 2016; 9():3501-9. PubMed ID: 27366087
[TBL] [Abstract][Full Text] [Related]
16. The miR-26a/AP-2α/Nanog signaling axis mediates stem cell self-renewal and temozolomide resistance in glioma.
Huang W; Zhong Z; Luo C; Xiao Y; Li L; Zhang X; Yang L; Xiao K; Ning Y; Chen L; Liu Q; Hu X; Zhang J; Ding X; Xiang S
Theranostics; 2019; 9(19):5497-5516. PubMed ID: 31534499
[TBL] [Abstract][Full Text] [Related]
17. ZNF384 transcriptionally activated MGST1 to confer TMZ resistance of glioma cells by negatively regulating ferroptosis.
Yan T; Hu P; Lv S; Ye M; Wu M; Fang H; Xiao B
Cancer Chemother Pharmacol; 2024 Jun; ():. PubMed ID: 38824270
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-34a-5p suppresses tumorigenesis and progression of glioma and potentiates Temozolomide-induced cytotoxicity for glioma cells by targeting HMGA2.
Ma S; Fu T; Zhao S; Gao M
Eur J Pharmacol; 2019 Jun; 852():42-50. PubMed ID: 30851271
[TBL] [Abstract][Full Text] [Related]
19. MiR-16 modulate temozolomide resistance by regulating BCL-2 in human glioma cells.
Han J; Chen Q
Int J Clin Exp Pathol; 2015; 8(10):12698-707. PubMed ID: 26722459
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-27a-3p inhibits cell viability and migration through down-regulating DUSP16 in hepatocellular carcinoma.
Li JM; Zhou J; Xu Z; Huang HJ; Chen MJ; Ji JS
J Cell Biochem; 2018 Jul; 119(7):5143-5152. PubMed ID: 29143999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
